Last Updated : July 20, 2015
Details
FilesGeneric Name:
Asfotase alfa
Project Status:
Complete
Therapeutic Area:
Hypophosphatasia, pediatric-onset
Manufacturer:
Alexion Pharmaceuticals Canada
Call for patient/clinician input open:
Brand Name:
Strensiq
Project Line:
Reimbursement Review
Project Number:
SR0443-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Hypophosphatasia, pediatric-onset
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : July 20, 2015